Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

Topic

 

The PMI Turns One - How Will We Measure Success?

In a July 1 editorial, the Lancet (free registration required) praised the US President's Malaria Initiative (PMI) which was celebrating the one year anniversary of its founding. Although much quieter than its older brother, PEPFAR, the PMI has slowly and softly helped revolutionize the battle against malaria by concentrating resources to make substantial gains against the disease. However, this model is not without its critics. According to the article:

Being smart with Buffett's billions

Big money is big news so it is no surprise that the recent announcement of Buffett's billions going to the Gates Foundation is making headlines. But rather than focus on the who, what, when, where, and how much, this recent Boston Globe article, Measures of Success, asks how these new philanthropic dollars will be judged once spent.

Real Partnership

The second Global Fund Partnership Forum concluded yesterday in Durban, South Africa. About 400 people representing 118 countries from around the world attended. What was most remarkable about the Forum is that the Global Fund intentionally brought together not just its most vocal supporters but also its most strident critics, and then gave them two days to discuss what was working and what needs to be fixed. It says a lot about an organization when it intentionally creates opportunities to be criticized.

Uganda investigating possible misuse of GAVI funds

Following an inquiry into the corruption and mismanagement of Global Fund grants in Uganda, the New Vision has recently reported that the Ministry of Health is now under investigation for possible misuse of sh300m (approximately US$160,000) in GAVI funding intended to increase immunization coverage.

NOTE: The article does not name its sources and we were unable to independently verify the accuracy of this account

Arata Kochi: Leading the fight against malaria

Dr. Arata Kochi, Director of the WHO Global Malaria Programme, has received a lot of press recently for his aggressive approach to curbing malaria in developing countries - particularly in light of his crackdown on suppliers of artemisinin monotherapies.

Pages